Scandinavian ChemoTech AB (publ) has signed a new contract for a new installation of the IQwave and TSE (Tumour Specific Electroporation) device with Chhatrapati Shivaji Subharti Hospital (CSSH) & Medical College. The installation consists of a training and an integration phase. The initial non-commercial phase is limited to one month and will then, if approved by the hospital administration, enter the commercial phase.

If approved the signed agreement will amount to a minimum consumption of kits equal to EUR 70,000 per year.